Makhzoumi Mohamad (CIK 0001630226)

Latest company ownership

Role: 10% Owner
Shares held
24,471,264
Last filed at
Jul 19, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q3 2025Q4
Shares held
3,000,000
Last filed at
Apr 13, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q2 2025Q4
Role: 10% Owner
Shares held
2,091,383
Last filed at
Sep 17, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2024Q3 2025Q4
Shares held
1,989,872
Last filed at
Apr 15, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4
Role: 10% Owner
Shares held
1,712,810
Last filed at
Jul 16, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q3 2025Q4
Shares held
1,625,678
Last filed at
Dec 23, 2024
Confidence Score
50.1
2025Q4
Confidence Score History
2021Q1 2025Q4
Role: Director
Shares held
1,352,200
Last filed at
Oct 6, 2025
Confidence Score
32.2
2025Q4
Confidence Score History
2021Q2 2025Q4
Role: 10% Owner
Shares held
1,090,793
Last filed at
Apr 24, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2024Q2 2025Q4
Shares held
669,002
Last filed at
Jun 30, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4
Shares held
11,348
Last filed at
Jun 15, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q3 2025Q4
Role: 10% Owner
Shares held
1,654
Last filed at
Nov 18, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q2 2025Q4
Role: 10% Owner
Shares held
0
Last filed at
Dec 22, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q1 2025Q4
Shares held
0
Last filed at
May 4, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Oct 2, 2025 Oct 6, 2025 NeueHealth, Inc. Director Sell 26.3 -6,245,669 -32.62% $39.5K
Dec 23, 2024 Dec 23, 2024 Marker Therapeutics, Inc. 10% Owner Buy 100.0 +554,250 51.73% $1.8M
Sep 16, 2024 Sep 17, 2024 MBX Biosciences, Inc. 10% Owner Buy 100.0 +500,000 16.05% $8M
Apr 22, 2024 Apr 24, 2024 Korro Bio, Inc. 10% Owner Buy 85.0 +17,857 1.66% $1000K
Jul 17, 2023 Jul 19, 2023 Savara Inc 10% Owner Buy 85.0 +333,333 1.38% $1000K
Dec 20, 2022 Dec 22, 2022 Arcellx, Inc. 10% Owner Sell 27.5 -1,999,717 -29.65% $5.5K
Jun 21, 2022 Jun 23, 2022 Arcellx, Inc. 10% Owner Buy 93.8 +312,500 4.86% $5M
May 26, 2022 May 31, 2022 IonQ, Inc. 10% Owner Sell 15.0 -2,922,966 -10.00% $17.1M
May 2, 2022 May 4, 2022 Robinhood Markets, Inc. Director Sell 26.3 -23,819,826 -49.99% $19.6K
Apr 11, 2022 Apr 13, 2022 Trevi Therapeutics, Inc. 10% Owner Buy 100.0 +3,580,526 45.96% $6.8M
Feb 8, 2022 Feb 9, 2022 Arcellx, Inc. 10% Owner Buy 100.0 +1,583,333 32.65% $23.7M
Jan 28, 2022 Feb 1, 2022 Robinhood Markets, Inc. Director Sell 26.3 -23,863,239 -33.37% $29.6K
Jun 28, 2021 Jun 30, 2021 NeueHealth, Inc. Director Buy 95.0 +1,944,444 2.78% $35M
Jun 28, 2021 Jun 30, 2021 Monte Rosa Therapeutics, Inc. 10% Owner Buy 100.0 +1,050,000 15.81% $20M
Apr 13, 2021 Apr 15, 2021 OnKure Therapeutics, Inc. 10% Owner Buy 100.0 +666,666 16.19% $10M
Mar 16, 2021 Mar 18, 2021 Marker Therapeutics, Inc. 10% Owner Buy 100.0 +5,714,285 114.29% $10M
Jul 14, 2020 Jul 16, 2020 Nkarta, Inc. 10% Owner Buy 100.0 +666,666 29.82% $12M
Apr 3, 2020 Apr 13, 2020 Trevi Therapeutics, Inc. 10% Owner Sell 52.5 -564 -0.01% $1.5K
Jul 22, 2019 Jul 24, 2019 Mirum Pharmaceuticals, Inc. 10% Owner Buy 100.0 +450,000 12.04% $6.8M
May 9, 2019 May 13, 2019 Trevi Therapeutics, Inc. 10% Owner Buy 100.0 +2,500,000 128.96% $25M